SENIOR SECURED CONVERTIBLE NOTE DUE JANUARY 25th, 2027Psyence Biomedical Ltd. • June 6th, 2024 • Pharmaceutical preparations • New York
Company FiledJune 6th, 2024 Industry JurisdictionTHIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due January 25th, 2027 (this “Note”).